- Home
- KOD vs BRSP Comparison
KOD vs BRSP Comparison
Compare KOD & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KOD
- BRSP
- Stock Information
- Founded
- KOD 2009
- BRSP 2017
- Country
- KOD United States
- BRSP United States
- Employees
- KOD N/A
- BRSP N/A
- Industry
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- BRSP Real Estate Investment Trusts
- Sector
- KOD Health Care
- BRSP Real Estate
- Exchange
- KOD Nasdaq
- BRSP Nasdaq
- Market Cap
- KOD 795.5M
- BRSP 764.4M
- IPO Year
- KOD 2018
- BRSP 2018
- Fundamental
- Price
- KOD $14.09
- BRSP $5.13
- Analyst Decision
- KOD Buy
- BRSP Buy
- Analyst Count
- KOD 6
- BRSP 3
- Target Price
- KOD $14.33
- BRSP $6.00
- AVG Volume (30 Days)
- KOD 1.0M
- BRSP 678.3K
- Earning Date
- KOD 11-13-2025
- BRSP 10-28-2025
- Dividend Yield
- KOD N/A
- BRSP 12.48%
- EPS Growth
- KOD N/A
- BRSP N/A
- EPS
- KOD N/A
- BRSP N/A
- Revenue
- KOD N/A
- BRSP $335,107,000.00
- Revenue This Year
- KOD N/A
- BRSP N/A
- Revenue Next Year
- KOD N/A
- BRSP $6.74
- P/E Ratio
- KOD N/A
- BRSP N/A
- Revenue Growth
- KOD N/A
- BRSP N/A
- 52 Week Low
- KOD $1.92
- BRSP $4.16
- 52 Week High
- KOD $19.39
- BRSP $6.45
- Technical
- Relative Strength Index (RSI)
- KOD 56.85
- BRSP 22.83
- Support Level
- KOD $13.91
- BRSP $5.07
- Resistance Level
- KOD $17.12
- BRSP $5.51
- Average True Range (ATR)
- KOD 2.04
- BRSP 0.11
- MACD
- KOD -0.13
- BRSP -0.07
- Stochastic Oscillator
- KOD 46.80
- BRSP 3.95
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.